• NeuroSense Therapeutics Ltd. (NRSN) Latest Stock News & Headlines Yahoo Finance Tue, 07 Jul 2026 12:18:03 GMT
• Amyotrophic Lateral Sclerosis Market Trends, Innovation, and Future Growth Outlook to 2036 – DelveInsight | Helixmith, Sanofi, Den... Barchart.com Tue, 07 Jul 2026 00:30:21 GMT
• NeuroSense hosts ALS expert webinar to discuss PrimeC drug and Phase 3 trial plans. Pluang Mon, 06 Jul 2026 18:51:11 GMT
• NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS" PR Newswire Mon, 06 Jul 2026 12:45:00 GMT
• Enterprise value to revenue forward of NeuroSense Therapeutics Ltd. – NASDAQ:NRSN TradingView Sat, 04 Jul 2026 13:10:09 GMT
• NeuroSense Therapeutics Ltd. Warrant 2021-open end Financial Disclosures & SEC Filings TradingView Sat, 04 Jul 2026 00:29:18 GMT
• NeuroSense bolsters case for multi-target Alzheimer’s strategy Longevity.Technology Fri, 03 Jul 2026 16:10:02 GMT
• PrimeC Achieves Primary Biomarker End Point in Phase 2b PARADIGM ALS Trial NeurologyLive Fri, 03 Jul 2026 01:49:22 GMT
• NRSN Q2 2025 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline Amid Clinical Progress - Diluted EPS Report dars.gov.et Thu, 02 Jul 2026 15:31:37 GMT
• NeuroDex ExoSORT Platform Demonstrates Treatment-Responsive Blood-Based Measurement of Neuronal TDP-43 in People Living with ALS The Grand Junction Daily Sentinel Wed, 01 Jul 2026 17:18:28 GMT
• Oral ALS treatment lowers toxic protein levels, extends survival ALS News Today Wed, 01 Jul 2026 17:17:32 GMT
• Amyotrophic Lateral Sclerosis Market Gains Momentum with Expanding Pipeline and Investment Potential by 2034 – DelveInsight | Heli... Barchart.com Wed, 01 Jul 2026 13:34:17 GMT
• neurosense therapeutics ltd. warrant 2021-open end financial disclosures & sec filings TradingView Wed, 01 Jul 2026 10:16:07 GMT
• proof-of-concept trial suggests investigational primec engages multiple alzheimer disease biomarkers NeurologyLive Tue, 30 Jun 2026 17:40:36 GMT
• NeuroSense Says Phase 2b Trial of PrimeC in Amyotrophic Lateral Sclerosis Meets Primary Endpoint Moomoo Mon, 29 Jun 2026 14:00:42 GMT
• NeuroSense (NRSN) Phase 2b ALS study cuts TDP-43, eyes Phase 3 Stock Titan Mon, 29 Jun 2026 13:30:29 GMT
• NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathol... PR Newswire Mon, 29 Jun 2026 13:30:00 GMT
• NeuroSense’s ALS drug cuts key biomarker in Phase IIb trial Clinical Trials Arena Mon, 29 Jun 2026 07:00:00 GMT
• Neurosense Therapeutics Achieves Primary Endpoint In Phase 2B ALS Study TradingView Mon, 29 Jun 2026 07:00:00 GMT
• NeuroSense reports Phase 2 biomarker findings for PrimeC in Alzheimer’s disease BioSpectrum Asia Fri, 26 Jun 2026 05:20:09 GMT
• neurosense therapeutics ltd. actuals & estimates (nasdaq:nrsn) TradingView Fri, 26 Jun 2026 00:01:15 GMT
• price to earnings forward of neurosense therapeutics ltd. – nasdaq:nrsnw TradingView Thu, 25 Jun 2026 20:59:29 GMT
• price to book forward of neurosense therapeutics ltd. – nasdaq:nrsnw TradingView Thu, 25 Jun 2026 16:38:22 GMT
• number of shareholders of neurosense therapeutics ltd. – fwb:h1z TradingView Thu, 25 Jun 2026 15:00:52 GMT
• Beyond Amyloid: A New Multi-Target Strategy Shows Early Promise for Alzheimer’s BriefGlance Thu, 25 Jun 2026 12:20:00 GMT
• NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease PR Newswire Thu, 25 Jun 2026 07:00:00 GMT
• NeuroSense (NRSN) reports early Phase 2 PrimeC biomarker signals in Alzheimer’s Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• NeuroSense’s Alzheimer’s study shows biomarker shifts in eight patients Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• price to sales forward of neurosense therapeutics ltd. – nasdaq:nrsnw TradingView Thu, 25 Jun 2026 03:15:27 GMT
• enterprise value to ebit forward of neurosense therapeutics ltd. – nasdaq:nrsnw TradingView Wed, 24 Jun 2026 22:04:38 GMT
• Leal Therapeutics Doses First Patient in NeurALS Phase 1/2 Trial of LTX-002 for Amyotrophic Lateral Sclerosis (ALS) Yahoo Finance Tue, 23 Jun 2026 07:00:00 GMT
• NeuroSense Therapeutics (NRSN) Q2 2025 Earnings: EPS Beat Amid Pre-Revenue Phase; Stock Declines - Net Income Trends dars.gov.et Tue, 23 Jun 2026 07:00:00 GMT
• everythingals to host neurosense in a community event named: primec - connecting the dots StreetInsider Tue, 23 Jun 2026 00:24:27 GMT
• neurometrix strategy shifts toward digital therapeutics, shares on nasdaq remain speculative Ad-hoc-news.de Mon, 22 Jun 2026 14:01:39 GMT
• EverythingALS to Host NeuroSense in a Community Event Named: PrimeC - Connecting the Dots Barchart.com Mon, 22 Jun 2026 13:00:00 GMT
• nrsn q2 2025 earnings: narrower loss per share beats estimates, stock surges - earnings beat streak dars.gov.et Sat, 20 Jun 2026 07:00:00 GMT
• neurosense therapeutics ltd (nrsn) dividends & stock splits: historical payouts and event timeline TradingKey Fri, 19 Jun 2026 03:55:05 GMT
• Neurosense Therapeutics Ltd (NRSN) Shareholder Structure: Major Shareholders & Institutional Holdings TradingKey Fri, 19 Jun 2026 01:26:29 GMT
• Neurosense Therapeutics Ltd (NRSNW) Financial Health: Profitability & Balance Sheet Analysis TradingKey Thu, 18 Jun 2026 17:42:38 GMT
• Neurosense Therapeutics Ltd (NRSNW) Institutional Confidence TradingKey Thu, 18 Jun 2026 17:41:31 GMT
• neurosense therapeutics ltd (nrsnw) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 16:55:14 GMT
• neurosense therapeutics ltd (nrsnw) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 16:54:57 GMT
• neurosense therapeutics ltd (nrsnw) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 16:41:21 GMT
• neurosense therapeutics ltd (nrsn) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 09:23:23 GMT
• neurosense therapeutics ltd (nrsnw) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 08:52:46 GMT
• neurosense therapeutics ltd (nrsnw) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 08:47:30 GMT
• NeuroSense (NRSN) CEO acquires 250,000 shares in private placement Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• NeuroSense (NRSN) CFO acquires 250,000 shares in private placement Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• NRSN Q2 2025 Earnings: Narrower-than-Expected Loss Drives Positive Market Reaction - Earnings Per Share dars.gov.et Wed, 17 Jun 2026 07:00:00 GMT
• 12 health care stocks moving in wednesday's after-market session Sahm Wed, 17 Jun 2026 07:00:00 GMT
• neurosense therapeutics ltd (nrsnw) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• neurosense therapeutics ltd (nrsn) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 05:23:44 GMT
• neurosense therapeutics ltd (nrsn) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 04:53:02 GMT
• neurosense therapeutics ltd (nrsn) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 04:49:45 GMT
• neurosense therapeutics ltd (nrsn) institutional confidence TradingKey Wed, 17 Jun 2026 04:48:56 GMT
• neurosense therapeutics ltd (nrsnw) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• neurosense therapeutics ltd (nrsnw) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• neurosense therapeutics ltd (nrsn) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• Neurosense, Health Canada discuss approval path for PrimeC ALS News Today Fri, 12 Jun 2026 07:00:00 GMT
• ALS pill candidate PrimeC gains South Korea patent to 2042 Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• NeuroSense Therapeutics Ltd. (NRSN) Q2 2025 Earnings: Narrower-than-Expected Loss Marks Progress Amid Clinical-Stage Operations - ... dars.gov.et Thu, 11 Jun 2026 07:00:00 GMT
• neurosense granted south korean patent covering primec composition for als Morningstar Thu, 11 Jun 2026 07:00:00 GMT
• neurosense (nasdaq: nrsn) secures south korean patent protection for als therapy primec Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• roth mkm maintains neurosense therapeutics(nrsn.us) with buy rating, maintains target price $3 Moomoo Wed, 10 Jun 2026 18:28:05 GMT
• japan grants 2042 patent on als drug combo: neurosense's primec Stock Titan Tue, 09 Jun 2026 13:00:00 GMT
• NeuroSense Therapeutics Receives Japanese Patent Grant for PrimeC Novel Composition PR Newswire Tue, 09 Jun 2026 07:00:00 GMT
• Japanese patent extends PrimeC protection to 2042 for NeuroSense (NRSN) Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• neurosense therapeutics ltd (nasdaq: nrsn) share price, nrsn stock news, nrsn share price & updates Kalkine Mon, 08 Jun 2026 21:49:20 GMT
• neurosense therapeutics advances canadian regulatory talks on als drug primec TipRanks Mon, 08 Jun 2026 13:32:46 GMT
• NeuroSense (NRSN) advances Health Canada discussions on PrimeC ALS regulatory path Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• NRSN Q2 2025 Earnings: Narrower-than-Expected Loss Signals Cost Discipline - EBITDA Analysis dars.gov.et Mon, 08 Jun 2026 07:00:00 GMT
• NRSN Q2 2025 Earnings: EPS Surprises to the Upside Despite No Revenue, Stock Dips Slightly - Upward Estimate Revision dars.gov.et Mon, 01 Jun 2026 07:00:00 GMT
• nrsn q2 2025 earnings: narrower-than-expected loss fails to lift shares - analyst drop coverage dars.gov.et Mon, 01 Jun 2026 07:00:00 GMT
• neurosense therapeutics (nrsn) faces 4.5% decline—key support at $0.78 holds the line - price action signals The Legal Advocate Sat, 30 May 2026 01:30:23 GMT
• NeuroSense Therapeutics (NRSN) Slides 3.94%, Pivots Near Key Support at $0.82 - Put Call Ratio dars.gov.et Thu, 28 May 2026 07:00:00 GMT
• NeuroSense Therapeutics (NRSN) Edges Higher, Testing Resistance at $0.95 - CTA Positioning dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• outsee selected for discovery award from longitude prize on als to accelerate ai-based target discovery Yahoo Finance Tue, 19 May 2026 07:00:00 GMT
• brainstorm cell therapeutics announces aggregate of $400,000 in private placements priced at premium to market Yahoo Finance Tue, 19 May 2026 07:00:00 GMT
• brainstorm cell therapeutics announces first quarter 2026 financial results and provides corporate update Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• neurosense secures insider-led $600,000 pipe at premium share price The Globe and Mail Wed, 29 Apr 2026 07:00:00 GMT
• neurosense therapeutics receives nasdaq notices over listing requirements MSN Wed, 29 Apr 2026 06:05:51 GMT
• neurosense announces pricing of insider-led pipe financing The Malaysian Reserve Wed, 29 Apr 2026 00:15:57 GMT
• neurosense therapeutics receives nasdaq notices over listing requirements MSN Tue, 28 Apr 2026 20:12:37 GMT
• NeuroSense (Nasdaq: NRSN) insiders lead $600K PIPE financing at premium Stock Titan Tue, 28 Apr 2026 07:00:00 GMT
• NeuroSense Announces Pricing of Insider-Led PIPE Financing PR Newswire Tue, 28 Apr 2026 07:00:00 GMT
• NeuroSense CEO, CFO and investor commit $600K at a premium Stock Titan Tue, 28 Apr 2026 07:00:00 GMT
• neurosense secures insider-led $600,000 pipe at premium share price TipRanks Tue, 28 Apr 2026 07:00:00 GMT
• roth mkm maintains neurosense therapeutics(nrsn.us) with buy rating, maintains target price $3 Moomoo Mon, 27 Apr 2026 15:32:01 GMT
• neurosense therapeutics ltd. announced that it expects to receive $0.6 million in funding marketscreener.com Mon, 27 Apr 2026 07:00:00 GMT
• neurosense ceo, cfo and investor commit $600k at a premium Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• neurosense therapeutics receives nasdaq notices over listing requirements MSN Mon, 27 Apr 2026 03:54:11 GMT
• neurosense therapeutics receives nasdaq notices over listing requirements MSN Sun, 26 Apr 2026 18:11:15 GMT
• neurosense therapeutics transitions chief medical officer to advisory role ahead of key primec milestones The Globe and Mail Sat, 25 Apr 2026 07:00:00 GMT
• NeuroSense (NRSN) CMO steps down but stays on as advisor for PrimeC Stock Titan Fri, 24 Apr 2026 07:00:00 GMT
• neurosense therapeutics transitions chief medical officer to advisory role ahead of key primec milestones TipRanks Fri, 24 Apr 2026 07:00:00 GMT
• neurosense therapeutics receives nasdaq notices over listing requirements MSN Thu, 23 Apr 2026 14:02:49 GMT
• tangible book value per share of neurosense therapeutics ltd. – nasdaq:nrsnw TradingView Fri, 17 Apr 2026 20:51:37 GMT
• ebit per share of neurosense therapeutics ltd. – nasdaq:nrsnw TradingView Fri, 17 Apr 2026 20:50:19 GMT
• operating cash flow per share of neurosense therapeutics ltd. – nasdaq:nrsnw TradingView Fri, 17 Apr 2026 20:45:34 GMT
• neurosense therapeutics ltd (nrsn) earnings history & surprises ChartMill Fri, 17 Apr 2026 07:00:00 GMT
• d boral capital maintains neurosense therapeutics (nrsn) buy recommendation MSN Fri, 17 Apr 2026 02:41:19 GMT
• d boral capital maintains neurosense therapeutics (nrsn) buy recommendation MSN Tue, 14 Apr 2026 21:02:02 GMT
• form 20-f - annual and transition report of foreign private issuers [sections 13 or 15(d)] ADVFN Mon, 13 Apr 2026 14:48:24 GMT
• sentiment review: is neurosense therapeutics ltd equity warrant benefiting from interest rate changes - portfolio gains summary & ... baoquankhu1.vn Mon, 13 Apr 2026 13:47:18 GMT
• nasdaq moves: is neurosense therapeutics ltd equity warrant showing insider buying - portfolio value report & real-time sentiment ... baoquankhu1.vn Mon, 13 Apr 2026 03:09:29 GMT
• patterns watch: is neurosense therapeutics ltd equity warrant part of any etf - 2026 top decliners & real-time price movement repo... baoquankhu1.vn Sun, 12 Apr 2026 09:10:27 GMT
• if you invested $1,000 in neurosense therapeutics ltd (nrsn) Stock Titan Fri, 10 Apr 2026 04:47:40 GMT
• trend report: is neurosense therapeutics ltd equity warrant showing insider buying - weekly risk report & ai powered buy/sell reco... baoquankhu1.vn Thu, 09 Apr 2026 17:05:18 GMT
• bank watch: is neurosense therapeutics ltd equity warrant showing insider buying - market weekly review & daily stock trend report... baoquankhu1.vn Thu, 09 Apr 2026 11:01:07 GMT
• chipmakers recap: why is neurosense therapeutics ltd stock going down - earnings growth summary & weekly market pulse alerts baoquankhu1.vn Thu, 09 Apr 2026 00:02:17 GMT
• aug highlights: what are neurosense therapeutics ltd equity warrants earnings expectations - 2026 earnings surprises & low risk en... baoquankhu1.vn Wed, 08 Apr 2026 20:16:24 GMT
• chipmakers recap: why is neurosense therapeutics ltd stock going down - earnings growth summary & weekly market pulse alerts baoquankhu1.vn Wed, 08 Apr 2026 12:04:10 GMT
• inflation data: is neurosense therapeutics ltd equity warrant stock undervalued right now - earnings summary report & free high ac... baoquankhu1.vn Wed, 08 Apr 2026 10:28:58 GMT
• volatility watch: can neurosense therapeutics ltd equity warrant keep up with sector leaders - 2026 price momentum & ai powered bu... baoquankhu1.vn Wed, 08 Apr 2026 07:33:36 GMT
• nrsn analyst rating update: d. boral capital maintains 'buy' rat GuruFocus Wed, 08 Apr 2026 07:00:00 GMT
• breakout watch: is neurosense therapeutics ltd gaining market share - 2026 review & consistent profit focused trading strategies baoquankhu1.vn Wed, 08 Apr 2026 05:41:53 GMT
• roth mkm maintains neurosense therapeutics(nrsn.us) with buy rating, maintains target price $3 Moomoo Tue, 07 Apr 2026 19:50:48 GMT
• income plays: is neurosense therapeutics ltd stock a value trap - 2026 alltime highs & short-term trading opportunity alerts baoquankhu1.vn Tue, 07 Apr 2026 19:28:56 GMT
• breakout watch: is neurosense therapeutics ltd gaining market share - 2026 review & consistent profit focused trading strategies baoquankhu1.vn Tue, 07 Apr 2026 17:41:14 GMT
• is neurosense therapeutics ltd stock a buy or sell - market trend report & weekly consistent profit watchlists baoquankhu1.vn Tue, 07 Apr 2026 16:03:59 GMT
• if you invested $1,000 in neurosense therapeutics ltd (nrsn) Stock Titan Tue, 07 Apr 2026 10:37:46 GMT
• neurosense granted brazilian patent covering primec composition TipRanks Tue, 07 Apr 2026 03:14:15 GMT
• neurosense therapeutics receives nasdaq notices over listing requirements MSN Mon, 06 Apr 2026 12:31:02 GMT
• neurosense granted brazilian patent covering primec composition PR Newswire Mon, 06 Apr 2026 07:00:00 GMT
• brazil grants neurosense (nrsn) patent protecting primec als and alzheimer’s drug Stock Titan Mon, 06 Apr 2026 07:00:00 GMT
• brazil grants neurosense als drug patent protection through 2042 Stock Titan Mon, 06 Apr 2026 07:00:00 GMT
• neurosense wins long-term brazilian patent protection for als drug primec TipRanks Mon, 06 Apr 2026 07:00:00 GMT
• neurosense therapeutics announces receipt of nasdaq notifications regarding minimum bid price and market value requirements marketscreener.com Mon, 06 Apr 2026 07:00:00 GMT
• neurosense therapeutics receives nasdaq notices over listing requirements MSN Sun, 05 Apr 2026 17:59:28 GMT
• aug sentiment: is neurosense therapeutics ltd in a consolidation phase - 2026 summary & intraday high probability setup alerts baoquankhu1.vn Sun, 05 Apr 2026 07:28:05 GMT
• if you invested $1,000 in neurosense therapeutics ltd (nrsn) Stock Titan Sun, 05 Apr 2026 03:29:12 GMT
NeuroSense Therapeutics Ltd.(NASDAQ:NRSN) 
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. Its lead product is PrimeC, an extended-release oral formulation of a fixed dose combination of ciprofloxacin an...
Website: https://www.neurosense-tx.com
Founded: 2017
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends